Pfizer Limited (PFIZER.BO)
INR 4191.9
(2.75%)
INR 4191.9
(2.75%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 21.93 Billion | 24.24 Billion | 26.1 Billion | 22.38 Billion | 21.51 Billion | 20.81 Billion |
| Cost of Revenue | 12.02 Billion | 8.73 Billion | 9.48 Billion | 7.97 Billion | 7.92 Billion | 7.47 Billion |
| Gross Profit | 9.9 Billion | 15.51 Billion | 16.62 Billion | 14.4 Billion | 13.59 Billion | 13.33 Billion |
| Operating Expenses | 4.33 Billion | 8.47 Billion | 9.42 Billion | 8.37 Billion | 8.84 Billion | 8.36 Billion |
| Selling, General and Administrative Expenses | 4.33 Billion | 3.26 Billion | 2.77 Billion | 2.35 Billion | 2.4 Billion | 2.27 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 1.01 Billion | 626.5 Million | 358.8 Million | 195 Million | 107.9 Million |
| Cost and Expenses | 12.32 Billion | 17.21 Billion | 18.9 Billion | 16.34 Billion | 16.76 Billion | 15.84 Billion |
| Operating Income | 9.61 Billion | 7.23 Billion | 7.4 Billion | 6.09 Billion | 4.86 Billion | 5.08 Billion |
| Interest Expense | 154.3 Million | 133.9 Million | 104.9 Million | 151.1 Million | 108.5 Million | 12.9 Million |
| Income Tax Expense | 1.94 Billion | 2 Billion | 1.6 Billion | 1.71 Billion | 1.33 Billion | 2.3 Billion |
| Earnings before Tax | 7.46 Billion | 8.24 Billion | 7.72 Billion | 6.68 Billion | 6.42 Billion | 6.59 Billion |
| Net Income | 5.51 Billion | 6.23 Billion | 6.12 Billion | 4.97 Billion | 5.09 Billion | 4.29 Billion |
| Earnings Per Share Basic | 120.51 | 136.38 | 133.89 | 108.77 | 111.28 | 93.78 |
| Earnings Per Share Diluted | 120.51 | 136.38 | 133.89 | 108.77 | 111.28 | 93.78 |
| Weighted Average Shares Outstanding | 45.75 Million | 45.75 Million | 45.75 Million | 45.75 Million | 45.75 Million | 45.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.75 Million | 45.75 Million | 45.75 Million | 45.75 Million | 45.75 Million | 45.75 Million |
| Gross Margin | 0.45 | 0.64 | 0.64 | 0.64 | 0.63 | 0.64 |
| EBIT Margin | 0.38 | 0.38 | 0.34 | 0.35 | 0.34 | 0.34 |
| Profit Margin | 0.25 | 0.26 | 0.23 | 0.22 | 0.24 | 0.21 |
| EBITDA | 8.23 Billion | 9.41 Billion | 8.97 Billion | 7.92 Billion | 7.55 Billion | 7.31 Billion |
| Earnings Before Tax Margin | 0.44 | 0.30 | 0.28 | 0.27 | 0.23 | 0.24 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.88 Billion | 5.62 Billion | 5.46 Billion | 21.93 Billion | 5.39 Billion | 5.75 Billion |
| Cost of Revenue | 2.1 Billion | 3.06 Billion | 2.78 Billion | 12.02 Billion | 1.82 Billion | 2.04 Billion |
| Gross Profit | 3.77 Billion | 2.56 Billion | 2.68 Billion | 9.9 Billion | 3.57 Billion | 3.7 Billion |
| Operating Expenses | 2.03 Billion | 933.1 Million | 927.5 Million | 4.17 Billion | 2.22 Billion | 2.03 Billion |
| Selling, General and Administrative Expenses | 878.6 Million | 933.1 Million | 927.5 Million | - | 1.15 Billion | 980.3 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 2.03 Billion | 418.4 Million | 751.3 Million | 1.8 Billion | 358.5 Million | 360.7 Million |
| Cost and Expenses | 4.14 Billion | 3.99 Billion | 3.7 Billion | 16.2 Billion | 4.04 Billion | 4.08 Billion |
| Operating Income | 1.74 Billion | 1.62 Billion | 1.75 Billion | 5.73 Billion | 1.35 Billion | 1.67 Billion |
| Interest Expense | 21 Million | 21.1 Million | 69.5 Million | 154.1 Million | 28.6 Million | 27.3 Million |
| Income Tax Expense | 568.8 Million | 519.1 Million | 650 Million | 1.94 Billion | 459.6 Million | 515.6 Million |
| Earnings before Tax | 2.15 Billion | 2.02 Billion | 2.43 Billion | 7.46 Billion | 1.75 Billion | 2 Billion |
| Net Income | 1.58 Billion | 1.5 Billion | 1.78 Billion | 5.51 Billion | 1.29 Billion | 1.48 Billion |
| Earnings Per Share Basic | 34.61 | 32.94 | 39.10 | - | 28.41 | 32.56 |
| Earnings Per Share Diluted | 34.61 | 32.94 | 39.10 | - | 28.41 | 32.56 |
| Weighted Average Shares Outstanding | 45.75 Million | 45.74 Million | 45.74 Million | 45.74 Million | 45.74 Million | 45.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.75 Million | 45.74 Million | 45.74 Million | 45.74 Million | 45.74 Million | 45.74 Million |
| Gross Margin | 0.64 | 0.46 | 0.49 | 0.45 | 0.66 | 0.64 |
| EBIT Margin | 0.39 | 0.32 | 0.35 | - | 0.35 | 0.38 |
| Profit Margin | 0.27 | 0.27 | 0.33 | 0.25 | 0.24 | 0.26 |
| EBITDA | 2.32 Billion | 1.77 Billion | 1.89 Billion | - | 1.88 Billion | 2.18 Billion |
| Earnings Before Tax Margin | 0.30 | 0.29 | 0.32 | 0.26 | 0.25 | 0.29 |
OCT
LODHA
CME
AUTOPINS
6272
9744